Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Preoperatively: Given intravenously on day one of the treatment cycle (once every 3 weeks) for four cycles

Preoperatively: Given intravenously on day 1 of the treatment cycle (once every three weeks) for three cycles Postoperatively: Intravenously for four 2-week cycles (once every two weeks) and after the 8 weeks (study doctor will determine course of treatment) for an additional four 2-week cycles with or with out paclitaxel

Postoperative: Given intravenously for four 2-week cycles

Postoperative: Given intravenously for four two-week cycles

Postoperative: 8 weeks after postoperative chemotherapy regimen (study doctor will determine course of treatment) paclitaxel for four 2-week cycles (once every two weeks)